Resultados de la búsqueda 681-690 of 12998 for actinic keratosis clinical trials
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. A Study to Test the ...
The purpose of this study is to determine endothelial gene expression from guidewire biopsy during clinically indicated endovascular procedures. The genetic ...
The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with ...
The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been ...
- Investigational Drug Sub-study A: Brigatinib. A Study to Develop Liquid Biopsy for Pediatric Brain Tumor Patients. Rochester, Minn. The purpose of this study ...
This will speed the pace of medical advancement and treatment recommendations for these conditions. Mayo Clinic Spinal Cord Injury (SCI) Rehabilitation Research ...
This study will include some patients receiving the hormone therapy and some patients ... clinical validity for recurrence detection and explore its value ...
Jacksonville, Fla. The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in ...
The purpose of the registry will be to support ongoing research in the etiology, early diagnosis, clinical management, and prognosis of lung cancer and other ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.